Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
Tags Biotech and Pharmaceuticals Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Companies Breaking news Biogen Inc
From CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
Tags Biotechnology Business Eli Lilly and Co
From CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
Tags Business Biotechnology Health & Science
From CNBC.com News
Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
Tags Pharmaceuticals Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Johnson & Johnson Healthy Returns Novo Nordisk A/S
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
Tags Health & Science Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Tags Eli Lilly and Co Zealand Pharma A/S Business
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags Health & Science Eli Lilly and Co Science
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Health care industry Pfizer Inc Companies
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags Investing Eli Lilly and Co Business
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags Eli Lilly and Co US: News Biotechnology
From CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
Tickers LAWS
Tags Technology Economic policy Dow Jones Industrial Average
From CNBC.com News
CNBC Daily Open: French far-right advance blocked
Tags Markets Economic outlook Breaking News: Technology
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags Science Diabetes Investing
From CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Tags Health care industry Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Altimmune Inc Eli Lilly and Co Health & Science
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Viking Therapeutics Inc Oracle Corp Health & Science
From CNBC.com News
5 things to know before the stock market opens
Tags NVIDIA Corp Business Paramount Global
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags Business Biotechnology US: News
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags US: News Eli Lilly and Co Business
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Zealand Pharma A/S Eli Lilly and Co Markets
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Health care industry Eli Lilly and Co Novo Nordisk A/S
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags US: News Eli Lilly and Co Business
From CNBC.com News
European stocks set for muted open after European Central Bank cut
Tags World Economy Government and politics World economy
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Eli Lilly and Co Employee benefits Health insurance
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Business News Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Cramer's Lightning Round: Apple is a buy
Tags Markets Datadog Inc Investment strategy
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.